Biotechnology Company Company Pharmaceutical Pharmacovigilance
|
The Truth About the Drug Companies During her two decades at The New England Journal of Medicine , Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering biotechnology company company pharmaceutical pharmacovigilance and manufacturing useful drugs biotechnology company company pharmaceutical pharmacovigilance and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, biotechnology company company pharmaceutical pharmacovigilance and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled biotechnology company company pharmaceutical pharmacovigilance and increasingly failed to meet spiraling prescription drug prices. Now, in this bold, hard-hitting new book, Dr. Angell exposes the shocking truth of what the pharmaceutical industry has become biotechnology company company pharmaceutical pharmacovigilance and argues for essential, long-overdue change. Currently Americans spend a staggering $200 billion each year on prescription drugs. As Dr. Angell powerfully demonstrates, claims that high drug prices are necessary to fund research biotechnology company company pharmaceutical pharmacovigilance and development are unfounded: The truth is that drug companies funnel the bulk of their resources into the marketing of products of dubious benefit. Meanwhile, as profits soar, the companies brazenly use their wealth biotechnology company company pharmaceutical pharmacovigilance and power to push their agenda through Congress, the FDA, biotechnology company company pharmaceutical pharmacovigilance and academic medical centers. Zeroing in on hugely successful drugs like AZT (the first drug to treat HIV/AIDS), Taxol (the best-selling cancer drug in history), biotechnology company company pharmaceutical pharmacovigilance and the blockbuster allergy drug Claritin, Dr. Angell demonstrates exactly how new products are brought to market. Drug companies, she shows, routinely rely on publicly funded institutions for their basic research; they rig clinical trials to make their products look better than they are; biotechnology company company pharmaceutical pharmacovigilance and they use their legions of lawyers to stretch out government-granted exclusive marketing rights for years. They also flood the market with copycat drugs that cost a lot more than the drugs they mimic but are no more effective. The American pharmaceut... Copyright (C) Muze Inc. 20
CLICK HERE FOR BEST PRICE
The Development Factory When the pharmaceuticals giant Merck reports promising results for a potential blockbuster drug, the story makes the evening news. Now, at a time when new product development has become critical to success in so many industries, The Development Factory proves that process innovation - not just product innovation - can be the key to competitive edge. In this multiyear study of pharmaceutical biotechnology company company pharmaceutical pharmacovigilance and biotechnology firms, Gary Pisano explores the dynamics of superior product biotechnology company company pharmaceutical pharmacovigilance and process development in a highly competitive industry that lives biotechnology company company pharmaceutical pharmacovigilance and dies by its R&D biotechnology company company pharmaceutical pharmacovigilance and depends heavily on rapid time to market. His work reveals that behind the success of many new product introductions lies the development of novel process technologies that provide lower costs, higher quality, biotechnology company company pharmaceutical pharmacovigilance and increased flexibility. Pisano challenges the widely held product-process life cycle view of competition, which suggests that industries tend to emphasize either product innovation or process innovation. He also questions the notion that there is a conflict between pursuit of product innovation biotechnology company company pharmaceutical pharmacovigilance and pursuit of lower costs, arguing that product development biotechnology company company pharmaceutical pharmacovigilance and process development capabilities are complementary. Extending the lessons to a wide variety of manufacturing industries, The Development Factory will guide companies toward unlocking the potential of process development biotechnology company company pharmaceutical pharmacovigilance and understanding the patterns of organizational behavior biotechnology company company pharmaceutical pharmacovigilance and managerial actions that help create biotechnology company company pharmaceutical pharmacovigilance and implement new capabilities over time. Copyright (C) Muze Inc. 2005. For personal use only. All rights reserved.
CLICK HERE FOR BEST PRICE
|
|
|
|
|
biotechnologycompanycompanypharmaceuticalpharmacovigilance
With comprehensive coverage, Applications of Surface-Enhanced Raman Spectroscopy provides practitioners of SERS with a resource of current applications described by experts in each area to guide their own applications of this technology. The third part then focuses on the key topics of molecular biotechnology, ranging from traditional micropipette to automated flow cytometeric methods * Includes purification, growth, maintenance, and cryopreservation techniques * Highlights methods for estimating algal populations, growth rates, isolating and measuring algal pigments, and detecting and culturing algal viruses * Features color photographs and illustrations throughout * Describes culturing methods ranging from functional genomics, proteomics and bioinformatics to drug targeting, recombinant antibodies, structural biology, gene therapy and knock mice. This book covers both the traditional applications in chemical and biochemical research as well as commercial applications in chemical and biochemical research as well as commercial applications in the areas of homeland security and medical applications. Offering groundwork for future application development, this text is essential for analytical chemists involved in trace chemical analysis and those companies selling SERS products. Researchers in industry, such as aquaculture, pharmaceutical, foodstuffs, and biotechnology companies will find an authoritative and comprehensive reference. Students of algal ecology, marine botany, marine phycology, and microbial ecology will enjoy the hands-on methodology for culturing a variety of algae from fresh and marine waters. The whole is rounded off by a section on biotechnology in industry dealing with patenting issues, company foundation and market opportunities. Written by exceptionally experienced experts from one of the world`s major biotech regions, the Heidelberg area, the authors come from academia, such well-known research centers as the German Cancer Research Center, and biotech companies. Over 800 pages this book provides students and professionals in life sciences, pharmacy and biochemistry with all they need to know about molecular biotechnology. It is
